Does a clearly elevated urinary mycophenolic acid result reflect immune-relevant exposure?

Mycophenolic acid (MPA) is a biologically active compound with well-established fungal production and immunosuppressive pharmacology. A urine result therefore warrants careful interpretation, particularly because it does not function like a validated measure of systemic immunosuppressive exposure.

Mechanism and immune effects

• MPA is produced by certain fungi, including Penicillium brevicompactum and P. roqueforti. In P. brevicompactum, disrupting the mpaC polyketide-synthase gene abolishes MPA production, directly establishing fungal biosynthesis.
• MPA directly and reversibly inhibits human inosine monophosphate dehydrogenase (IMPDH), particularly IMPDH II. Recombinant-enzyme inhibition constants were 50.8–57.7 nM, with an assay-specific IC50 of ~0.081 μM.
• IMPDH inhibition reduces guanine-nucleotide synthesis, limiting the proliferative capacity of activated T and B lymphocytes. In human whole blood, T-cell proliferation was inhibited with an IC50 of ~0.35 μM (0.113 mg/L), and ~95% inhibition occurred at 2 mg/L.

Interpreting an elevated urine result

• Detection of MPA-related material in urine is plausibly relevant to immune regulation because MPA itself is pharmacologically active. It does not, however, establish the extent, timing, or clinical consequence of immune effects.
• Urine predominantly contains inactive mycophenolic-acid glucuronide (MPAG): one 24-hour pharmacokinetic study estimated ~96% of administered dose was excreted as MPAG, versus ~1% as unchanged active MPA. Urinary concentrations therefore do not reliably predict plasma MPA exposure or lymphocyte suppression.
• A positive or elevated urine result cannot identify its source or establish mold-related illness. Food-related exposure, environmental exposure, prescribed drug exposure, contamination, and analytical factors cannot be distinguished by urinary MPA alone.

Bottom line

• MPA is a fungal metabolite and potent IMPDH-mediated suppressor of lymphocyte proliferation. An elevated urinary result is biologically meaningful as evidence of MPA-related analyte excretion, but it neither quantifies systemic immunosuppression nor proves a fungal, building-mold, or other specific exposure source.